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Purpose: The purpose of this study was to determine hypoglycemia fear and self-efﬁcacy levels of
patients receiving insulin and the factors affecting these levels.
Method: In total, 345 diabetic patients who met the inclusion criteria participated in this descriptive,
correlational study. Patients were invited to participate in the study during their regular visits to the
diabetes outpatient clinic of Istanbul University, Istanbul Medicine Faculty. Data were collected using
a patient-information form as well as the Hypoglycemia Fear Survey and Conﬁdence in Diabetes Self-care
Scale.
Results: It was found that patients who had type 1 diabetes, received intensive insulin therapy and
experienced more frequent and severe hypoglycemia had more hypoglycemia worry and fear. It was also
determined that patients who had type 1 diabetes and received intensive insulin therapy had higher self-
efﬁcacy levels than patients who had type 2 diabetes and received conventional therapy.
Conclusion: The effects of experiences of frequent and severe hypoglycemia in patients with diabetes
emphasize the need for programs that support diabetes-speciﬁc self-efﬁcacy and also guide and teach
hypoglycemia prevention.
Copyright  2011, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Insulin is indispensable for patients with type 1 diabetes, and it
becomes indispensable in time for patients with type 2 diabetes
due to the progressive nature of pancreatic beta cell failure.
However, paradoxically, although insulin treatment brings many
beneﬁts, it causes hypoglycemia, which is the most common and
feared complication of diabetes (Akram, Bjergaard, Carstenen,
Borch-Johnsen, & Thorsteinsson, 2006; Davis & Alonso, 2004;
Donnely et al., 2005; Stotland, 2006). The effectiveness of insulin
therapy in delaying the onset and reducing the progress of diabetes
complications in patients with type 1 and type 2 diabetes was
proven by the Diabetes Complications and Control Trial (DCCT
Research Group, 1993) and the United Kingdom Prospective Dia-
betes Study (UKPDS, 1998), respectively. However, the DCCT
demonstrated that strict glycemic control caused a three-fold
increase in the number of hypoglycemic events in patients with
type 1 diabetes, and the UKPDS established that the incidence
of hypoglycemia increased signiﬁcantly in patients with type 2
diabetes receiving insulin therapy.a University, Saglik Bilimleri
rean Society of Nursing Science. PuHypoglycemia is practically a part of life for individuals with type
1 diabetes and individuals with long-term type 2 diabetes (Brisco &
Davis, 2006). It is also known as amain barrier to achieving glycemic
goals (Brisco & Davis; Cox, Irvine, Gonder-Frederick, Nowacek, &
Butterﬁeld, 1987; Cryer, 2002; Cryer, Davis, & Shamoon, 2003;
Gabriely & Shamoon, 2004; Murata, Duckworth, Shah, Wendel, &
Hoffman, 2004; Wild et al., 2007; Yale et al., 2001). In particular,
severe and recurrent hypoglycemia leads to fear of hypoglycemia,
which negatively affects diabetes adherence and metabolic control.
Patients with high hypoglycemia fear may engage in behaviors such
as overeating, taking less insulin than required or limiting daily-life
activities (e.g., exercising, driving, shopping, visiting friends) in
order to avoid hypoglycemia. However, these types of coping
strategies lead to poor metabolic control and increase the risk of
health problems related to diabetes and psychosocial difﬁculties
(Cox et al., 1987). The signs and symptoms of hypoglycemia differ
from one individual to another (Davis & Alonso, 2004). Factors such
as old age, long diagnosis period and the existence of complications
impair hypoglycemia awareness. Studies have determined that 33%
of individuals with diagnosis periods longer than 15 years have
hypoglycemia unawareness (i.e., they are unaware of the signs and
symptoms of hypoglycemia). This has been found to increase the
risk of serious hypoglycemia, which increases hypoglycemia fear
(Cox et al.; Davis & Alonso; Frier, 2008; Geddes, Wright, Zammit,
Deary, & Frier, 2007). Kubiak, Hermanns, Schreckling, Kulzer andblished by Elsevier. All rights reserved.
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had impaired hypoglycemia awareness. In particular, patients who
experience sudden hypoglycemic attacks worry about losing
control, experiencing hypoglycemia while alone or sleeping or
making a mistake or having an accident during an attack (Cox &
Gonder-Frederick, 1992; Frier, 2008). Because they might not have
time to treat their hypoglycemia and might lose consciousness
suddenly, hypoglycemia has the potential to be life threatening.
Self-efﬁcacy reﬂects individuals’ ability to make behavioral
changes in order to adapt to chronic conditions and improve self-
care abilities (Van der Ven, Weinger, Pouwer, Ader, & Van der
Ploeg, 2003). Sigurdardottir (2005) states that self-efﬁcacy is
a powerful predictor of a person’s perceived self-care. Studies of
patients with type 2 diabetes demonstrated that greater self-
efﬁcacy predicted better nutrition and medication management,
more frequent self-monitoring of blood glucose and enhanced
physical activity (Dutton et al., 2009; King et al., 2010). While
higher levels of self-efﬁcacy have been seen as an indicator of better
diabetes control, lower levels have been seen as an indicator of
worse diabetes control (Glasgow, Tooberth, & Gilette, 2001). Wu,
Lee, Liang, Wang and Tung (2011) determined that a program
aimed at improving the self-efﬁcacy of patients with type 2 dia-
betes was effective in terms of short-term self-management. A
research suggested that patients who reported hypoglycemia fear
might actively attempt to avoid hypoglycemia by maintaining
higher than optimal glucose levels (Irvine, Cox, & Gonder-Frederick,
1992). Experiencing frequent or severe hypoglycemic attacks that
lead to unconsciousness might be related to lower self-efﬁcacy
levels regarding self-care behaviors. Thus, this study aimed to
determine hypoglycemia fear and self-efﬁcacy levels of patients
receiving insulin, and the factors affecting these levels.
Method
Setting and sample
The study sample consisted of 345 patients who were using
insulin and admitted to the Diabetes Outpatient Clinic of the
Department of Endocrinology and Metabolism Disease at Istanbul
Medical Faculty, Istanbul University. Each day, approximately 80
patients attend this outpatient clinic, which is open 3 days a week.
However, due to various reasons (e.g., meetings, congress, holi-
days), the outpatient clinic is closed for 4 weeks of the year. Thus,
approximately 10,560 patients with diabetes attend this outpatient
clinic in a year. As the general control period of the group was three
months, 2,500-3,000 patients with diabetes were being cared for
and controlled in a year. With a power analysis using a 95% conﬁ-
dence interval (CI), 50% hypoglycemia fear and self-efﬁcacy level
sample size was determined to be 333.
Data were collected between October 2007 and May 2008.
During this period, the researchers reached 378 patients that met
the inclusion criteria. However, because of incomplete data, 33 of
the forms were not included in the study, thus bringing the total
number to 345. Face-to-face interviews were conducted with the
patients who were waiting for their appointments with the
physician, diabetes nurse or dietitian. Suitable patients were
invited to a private room before or after their appointment. Patients
who were able to ﬁll out the forms ﬁlled the forms themselves and
asked questions when they needed; for those who wished to
participate the study but had vision problems or were too weak to
read and write, a researcher verbally presented the questions and
completed the forms according to the patient’s responses. Each
interview lasted for 20 minutes.
Inclusion criteriawere as follows: being 18 years or older, having
a diagnosis period of at least 1 year, having type 1 or type 2diabetes, using insulin, literate, able to ﬁll out the forms and will-
ingness to participate in the study. Patients who had psychiatric
disorders deﬁned in the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (American Psychiatric Association, 1994)
criteria were not included.
Instruments
The patient information form developed by the researchers
included both sociodemographic (e.g., age, income level, education,
employment status) and diabetes-related (e.g., diabetes type,
diagnosis year, medication, complications) questions.
For the Hypoglycemia Fear Survey (HFS; Cox et al., 1987) and the
Conﬁdence in Diabetes Self-care Scale (CIDS; Van der Ven et al.,
2003), the original developers of the instruments were contacted
and asked for permission to translate these scales into Turkish. The
above instruments were translated into Turkish and back-
translated into English. The original and back-translated English
versions of the instruments were assessed by the researchers and
a team composed of professionals working closely with patients
with diabetes, including clinical and academic nurses, physicians
and psychologists. When semantic differences between the two
instruments were found, the Turkish versions of the instruments
were revised and retranslated. After repeating the process until the
instruments were deemed acceptable, readability was tested with
ﬁve patients with diabetes mellitus before the ﬁnal versions of the
instruments were considered ready to use.
HFS, developed by Cox et al. (1987), is a 33-item questionnaire
with two subscales that measure (a) behaviors aimed at avoiding
hypoglycemia and its negative consequences and (b) worries about
hypoglycemia and its negative consequences. Responses are made
on a 5-point Likert scale where 0 means never and 4 means always.
Both subscales were used in this study, and higher scores indicated
increased fear of hypoglycemia. Internal consistency reliability
(Cronbach’s alpha) for the behavior subscale, worry subscale and
total HFS was found to be .77, .91 and .90, respectively.
CIDS, developed by Van der Ven et al. (2003), is a 20-item scale
that assesses diabetes-speciﬁc self-efﬁcacy and the perceived
ability to perform diabetes self-care tasks. Each item is rated on a 5-
point Likert scale ranging from 1 (No, I am sure I cannot) to 5 (Yes, I
am sure I can). A total CIDS score is calculated by summing all item
scores, with higher scores indicating higher self-efﬁcacy. Internal
consistency reliability for this scale was found to be .82.
The metabolic control of the patients was determined by look-
ing at the most recent records of the parameters (e.g., fasting/
postprandial glucose, glycosylated hemoglobin, chronic complica-
tions and lipid levels). Insulin regimens were reported as conven-
tional therapy for patients who received insulin one or two times
a day, intensive therapy for patients who received insulin three or
more times a day.
Ethical considerations
In order to conduct this research, permission had to be obtained
from the Department of Endocrinology and Metabolism Disease of
Istanbul University, Istanbul Medical Faculty. Ethical approval was
granted by the Ethics Committee of Istanbul University, Istanbul
Medical Faculty. Patients who met the inclusion criteria were
invited to participate in the study. Following this, the aim of the
study was explained, and verbal consent was obtained.
Data analysis
Data analysis was performed using SPSS (version 11.5; SPSS Inc.,
Chicago, IL, USA). Descriptive statistics, means, medians, frequencies
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characteristics, diabetes-related characteristics and scale scores.
Because the data were not normally distributed, nonparametric
tests were selected. The Mann-Whitney U and KruskaleWallis tests
and Spearman’s correlations were used to assess the factors
affecting the hypoglycemia fear and self-efﬁcacy levels of patients. A
p less than .05 was considered statistically signiﬁcant.
Results
Sociodemographic characteristics
The mean age of the group was 51.7114.12 years (range:
19e78). Of all participants, 59.7% (n¼ 206) were female, 69.9%
(n¼ 241) were married and 40.9% (n¼ 141) were primary-school
graduates. Nearly half of the sample had low income (46.7%,
n¼ 161), and 39.4% (n¼ 136) were homemakers (Table 1).
Diabetes-related characteristics
The mean diagnosis period of the patients was 13.17.55 years
(range: 1e38), and the mean insulin-usage period was 7.216.26
years (range: 1e38). Most of the group (72.5%, n¼ 250) had type 2
diabetes, 10.1% (n¼ 35) of the patients were hospitalized because
of diabetes or its complications and 44.3% (n¼ 153) of them were
using oral antidiabetic agents (OADs) in addition to insulin therapy.
More than half of the group (58%, n¼ 200) were being treated with
intensive insulin therapy (3 or more injections/day), and 61.7%
(n¼ 213) of the patients were using antihypertensives. Of all
participants, 53.0% (n¼ 183) carried out medical controls at 6-
month intervals. Moreover, 66.4% (n¼ 229) of the participants re-
ported that they had adequate education on diabetes, 70.7%
(n¼ 244)mentioned that they had education on hypoglycemia and
62.9% (n¼ 217) stated that this education was adequate (Table 2).
Patients’ mean fasting blood glucose was 150.98 57.53 mg/dL
(range: 35e433), postprandial blood glucose was 202.92
72.30 mg/dL (range: 55e480) and hemoglobin A1c was 7.98
1.47% (range: 5.10e13.70). Most patients (74.2%, n¼ 256) had one orTable 1
Comparison of Patients’ Demographic Characteristics and Hypoglycemia Fear and Self-ef
n % HFS-B
zMWU/X2KW p zMWU/X2K
Gender
Females 206 59.7 1.23 .215 2.50
Males 139 40.3
Marital status
Married 241 69.9 11.25 .004 7.53
Single 46 13.3
Widowed 58 16.8
Income level
Low 161 46.7 4.38 .111 0.08
Moderate 145 42.0
High 39 11.3
Education
Primary school 141 40.9 2.52 .471 2.29
Middle school 42 12.2
High school 72 20.9
University 90 26.1
Occupation
Housewife 136 39.4 16.53 .001 18.68
Retired 129 37.4
Government 38 11.1
Others 42 12.1
Notes. zMWU¼Mann-Whitney U, X2KW¼ Chi-square Kruskall-Wallis; HFS-B¼Hypog
HFS-T¼Hypoglcemia Fear Total Scale; CIDS¼ Conﬁdence in Diabetes Self-care Scale.more chronic complication, including hypertension (62.3%), reti-
nopathy (31.0%) and neuropathy (29.3%).
It was determined that 71.3% (n¼ 246) of the group had hypo-
glycemia with symptoms such as sweating, weakness, tension,
trembling and hunger in the last month, and 26.4% (n¼ 91) re-
ported that they had experienced severe hypoglycemia that led
to unconsciousness or treatment. According to patients’ reports,
without any signs or symptoms, 22.5% (n¼ 78) of the group found
their blood glucose levels to be under 3.8 mmol/L, and 40%
(n¼ 138) of the group found their blood glucose levels to be above
13 mmol/L.
Hypoglycemia fear and factors affecting hypoglycemia fear
Age, gender, marital status and occupation were the important
variables found to affect hypoglycemia fear. As age increased,
hypoglycemia fear (rs¼.24, p¼<.001), hypoglycemia worry
(rs¼.20, p¼<.001) and the frequency of behaviors performed to
avoid hypoglycemia (rs¼.25, p< .001) decreased (Table 3).
Women experienced more hypoglycemia worry than men did
(zMWU¼2.50, p¼ .012). Single patients had higher levels of
hypoglycemia fear (x2KW¼ 11.28, p¼ .004) and hypoglycemia
worry (x2KW¼ 7.53, p¼ .023) and performed behaviors to avoid
hypoglycemia more frequently (x2KW¼ 11.25, p¼ .004) than did
their married counterparts. Participants who were homemakers
also performed behaviors to avoid hypoglycemia more frequently
than those who were retired (x2KW¼ 16.53, p¼ 0.001). No signiﬁ-
cant relationship was found between hypoglycemia fear and
education or income level (Table 1).
Type of diabetes, period of diagnosis and insulin usage, insulin
treatment method, usage of OADs with insulin therapy and the
existence of a chronic complicationwere important diabetes-related
variables that were found to affect hypoglycemia fear. It was
determined that patients who had type 1 diabetes had more
hypoglycemia fear (zmwu¼6.69, p< .001) and worry
(zmwu¼5.53, p< .001) and performed avoidance behaviors more
frequently (zmwu¼6.86, p¼<.001) than patients with type 2
diabetes did. In addition, patients receiving intensive insulin therapyﬁcacy (N¼ 345).
HFS-W HFS-T CIDS
W p zMWU/X2KW p zMWU/X2KW p
.012 1.93 .050 0.71 0.47
.023 11.28 .004 25.64 < .001
.956 1.19 .549 18.03 < .001
.514 1.85 .603 46.44 < .001
< .001 20.95 < .001 13.22 .004
lycemia Fear Behavior Subscale, HFS-W¼Hypoglycemia Fear Worry Subscale;
Table 2
Comparison of Patients’ Diabetes Related Characteristics and Hypoglycemia Fear and Self-efﬁcacy (N¼ 345).
n % HFS-B HFS-W HFS-T CIDS
zMWU p zMWU p zMWU p zMWU p
Type of diabetes
Type 1 95 27.5 6.86 <.001 5.53 <.001 6.69 <.001 3.97 <.001
Type 2 250 72.5
Hospitalization history due to diabetes or diabetes related complications
Yes 35 10.1 2.78 .005 2.76 .006 3.22 .001 .72 .467
No 310 89.9
Use of OAD addition to insulin therapy
Yes 153 44.3 5.67 <.001 5.39 <.001 6.27 <.001 1.47 .141
No 192 55.7
Type of insulin therapy
Conventional 145 42.0 6.73 <.001 5.18 <.001 6.55 <.001 2.57 .010
Intensive 200 58.0
Having enough education about diabetes
Yes 229 66.4 0.28 .780 0.22 .821 0.26 .792 3.56 <.001
No 116 33.6
Having enough education about hypoglycemia
Yes 217 62.9 0.87 .383 1.09 .275 0.96 .332 3.18 .001
No 128 37.1
Notes. zMWU¼Mann-Whitney U; HFS-B¼Hypoglycemia Fear Behavior Subscale; HFS-W¼Hypoglycemia Fear Worry Subscale; HFS-T¼Hypoglcemia Fear Total Scale;
CIDS¼ Conﬁdence in Diabetes Self-care Scale; OAD¼ oral antidiabetic agent.
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(zmwu¼5.18, p¼<.001) and performed avoidance behaviors more
frequently (zmwu¼6.73, p< .001) than patients receiving
conventional therapy did (Table 2). It was found that as the diag-
nosis period increased,worries related to hypoglycemia increased as
well (rs¼ .11, p¼ .038). Moreover, as the insulin-usage period
increased, hypoglycemia fear (rs¼ .30, p< .001) and worry (rs¼ .28,
p¼<.001) and frequency of hypoglycemia-avoidance behaviors
(rs¼ .27, p¼<.001) increased (Table 3).
Patients who were receiving only insulin therapy had more
hypoglycemia fear (zmwu¼6.27, p¼<.001) and worry (zmwu¼
5.39, p¼<.001) and more frequent avoidance behaviors
(zmwu¼5.67, p¼<.001) than patients who were receiving OADs
with insulin therapy did. Thus, this study demonstrates that having
type 1 diabetes, experiencing frequent and severe hypoglycemia
and receiving insulin therapy (especially intensive insulin therapy)
are important variables associated with hypoglycemia fear.
Diabetes-related self-efﬁcacy and factors affecting self-efﬁcacy
As age increased, the diabetes-speciﬁc self-efﬁcacy levels of the
patients decreased. Patients who were single, had high levels of
income and high scores of self-perceived health had higher
diabetes-speciﬁc self-efﬁcacy scores. However, patients who were
homemakers and who were primary-school graduates had lower
diabetes-speciﬁc self-efﬁcacy scores. It was determined thatTable 3
Relationship Between Frequency of Hypoglycemia, Age, Diagnosis Period, Insulin Usage
HFS-B
rs p
Frequency of hypoglycemia in the last month .350 <.001
Frequency of severe hypoglycemia in the last yeara .390 <.001
Age .254 <.001
Diagnosis period .075 .166
Insulin usage period .273 <.001
Notes. rs¼ Spearman’s rho correlations; HFS-B¼Hypoglycemia Fear- Behaviour Subsca
Scale; CIDS¼ Conﬁdence in Diabetes Self-Care Scale.
a Severe hypoglycemia refers to that which leads to unconsciousness or requiring helparticipants who had type 1 diabetes, were receiving intensive
therapy, had diabetes education and reported that they had
adequate education about hypoglycemia also had higher diabetes-
speciﬁc self-efﬁcacy scores. Patients who had higher fasting and
postprandial blood glucose levels had lower diabetes-speciﬁc self-
efﬁcacy scores (Tables 1, 2 and 3).
As hypoglycemia fear increased, worry and avoidance behaviors
related to hypoglycemia increased as well. No signiﬁcant relation-
ship was found between hypoglycemia fear and worry and the
performance of avoidance behaviors and diabetes-speciﬁc self-
efﬁcacy levels (Table 4).
Discussion
Hypoglycemia is often seen as a main barrier to diabetes control
(Cryer, 2002; Cryer et al., 2003; Gabriely & Shamoon, 2004). As
insulin is indispensable for patients with type 1 diabetes, these
patients have a higher risk of hypoglycemia than those with type 2
diabetes do. Many studies have demonstrated that hypoglycemia
especially severe hypoglycemia is more frequently seen in patients
with type 1 diabetes (Donnely et al., 2005; Fanelli, Porcellati,
Pampanelli, & Bolli, 2004; Leese et al., 2003). In this study,
patients with type 1 diabetes carried out behaviors to avoid
hypoglycemia more frequently and exhibited more worry and fear
related to hypoglycemia. Myers, Boyer, Herbert, Barakat and
Scheiner (2007) determined that patients with type 1 diabetesPeriod and Hypoglycemia Fear and Self-efﬁcacy of Patients (N¼ 345).
HFS-W HFS-T CIDS
rs p rs p rs p
.334 <.001 .372 <.001 .050 .429
.395 <.001 .403 <.001 .039 .535
.209 <.001 .249 <.001 .286 <.001
.112 .038 .100 .064 .026 .625
.283 <.001 .305 <.001 .082 .127
le; HFS-W¼Hypoglycemia Fear-Worry Subscale; HFS-T¼Hypoglcemia Fear Total
p for recovery.
Table 4
Relationship Between Hypoglycemia Avoidance Behaviors, Hypoglycemia Worry,
Hypoglcemia Fear and Self-efﬁcacy (N¼ 345).
HFS-B
subgroup score
HFS-W
subgroup score
HFS-T score CIDS score
rs p rs p rs p rs p
HFS-B subgroup
score
  .666 <.001 .867 <.001 .075 .163
HFS-W subgroup
score
.666 <.001 L L .937 <.001 .005 .930
HFS-T score .867 <.001 .937 <.001 L L .030 .574
CIDS score .075 .163 .005 .930 .030 .574  L
Notes. rs¼ Spearman’s rho correlations; HFS-B¼Hypoglycemia Fear Behavior
Subscale; HFS-W¼Hypoglycemia Fear Worry Subscale; HFS-T¼Hypoglcemia Fear
Total Scale; CIDS¼ Conﬁdence in Diabetes Self-care Scale.
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enced signs and symptoms of post-traumatic stress disorder after
severe hypoglycemia attacks. Similar to these results, other studies
have shown that patients with type 1 diabetes have more hypo-
glycemia fear and worry than patients with type 2 diabetes
(Polonsky, Davis, Jacobson, & Anderson, 1992; Shiu & Wong, 2004).
Patients using oral antidiabetic agents in addition to insulin therapy
have also been found to perform behaviors to avoid hypoglycemia
less frequently and to have less worry and fear related to hypo-
glycemia. These patients had type 2 diabetes, and as they did not
experience frequent hypoglycemia attacks, they did not feel much
worry or fear. A study conducted by the United Kingdom
Hypoglycaemia Study Group (2007) stated that the hypoglycemia
risk of patients with type 2 diabetes increases after 5 years of
insulin usage.
It has been shown that intensive insulin therapy is the most
suitable way for patients with type 1 or type 2 diabetes and low
insulin reserves to prevent or delay diabetes-related complications
(DCCT, 1993; UKPDS, 1998). However, it has also been shown that
intensive therapy increases severe hypoglycemia attacks by 2e3
times (DCCT). This study also demonstrated that patients receiving
intensive therapy performed hypoglycemia avoidance behaviors
more frequently and experienced more worry and fear related to
hypoglycemia than patients receiving conventional insulin therapy
did.
Most of the patients reported that they had experienced hypo-
glycemia signs and symptoms in the last month. As the frequency of
hypoglycemia increased, behaviors to avoid hypoglycemia as well
as levels of worry and fear related to hypoglycemia increased as
well. Similar to this ﬁnding, Lundkvist, Berne, Bolinder, and Jönsson
(2005) also found a positive relationship between frequency of
hypoglycemia and worry and fear related to hypoglycemia. More-
over, Stargardt, Gonder-Frederick, Krobot and Alexander (2009)
stated that as the frequency and severity of hypoglycemia
increased, patients’ fear of hypoglycemia increased as well. Çelik
(2002) reported that as the frequency of hypoglyceemia
decreased, levels of depression and anxiety decreased, while well-
being increased. In this study, more than a quarter of the patients
mentioned that they had experienced severe hypoglycemia that led
to unconsciousness or treatment. It has been reported that 30% of
patients with type 1 diabetes experienced severe hypoglycemia in
Northern European countries (Leese et al., 2003). Another study
reported that 27.2% of patients with type 1 diabetes and 14.3% of
patients with type 2 diabetes experience severe hypoglycemic
attacks within a year time frame (Leiter et al., 2005). Studies have
determined that previous experiences related to severe hypogly-
cemia affect the development of hypoglycemia fear (Ter Braak et al.,
2000; Wild et al., 2007). This study showed that as the frequency of
severe hypoglycemia increased, behaviors aimed at avoidinghypoglycemia, and worry and fear related to hypoglycemia
increased as well. In line with this result, Polonsky et al. (1992)
found that patients with severe hypoglycemia exhibited more
hypoglycemia worries.
Diabetes is a chronic health problem demanding complex
treatment and care. The goal of diabetes treatment and care is to
achieve glycemic control and to prevent acute and chronic
complications of diabetes. Diabetes care is an important and
comprehensive concept, including a balance between medical
therapy, nutrition, exercise and blood glucose monitoring. The
outcome of diabetes treatment is highly dependent on whether
patients have healthy lifestyles and the on-going motivation to
adhere to diabetes treatment. Of all chronic diseases, diabetes
requires the most number of behavioral changes in order to
succeed in management (Cox & Gonder-Frederick, 1992). When
a patient receiving insulin therapy makes the necessary lifestyle
changes and complies with these basic components, her/his
hypoglycemia frequency decreases. As intensive insulin therapy
requires three or more daily injections, patients receiving intensive
insulin therapy have to make more signiﬁcant lifestyle changes in
order to adhere to their insulin regimens. Otherwise, they can
experience frequent or severe hypoglycemia attacks, which can
negatively impact their lives and create psychological problems
such as hypoglycemia fear. Therefore, as was expected, diabetes-
speciﬁc self-efﬁcacy levels of patients receiving intensive insulin
therapy were found to be higher than those of patients receiving
conventional therapy in this study.
It has been determined that as age increased, the diabetes-
speciﬁc self-efﬁcacy levels of the patients decreased. This may be
because as age increases, the burden of living with a chronic
condition such as diabetes increases as well. Moreover, patients’
motivation to adhere to diabetes treatment and maintain a healthy
lifestyle could decrease over time. This study found that partici-
pants with higher levels of education had higher diabetes-speciﬁc
self-efﬁcacy scores. Other studies have also found a positive rela-
tionship between education level and self-efﬁcacy (Meers et al.,
1996; Mollaoglu & Bag, 2009; Qiao & Shiu, 2004). This may be
related to the fact that higher education brings higher levels of
knowledge of, awareness of and sensitivity to health problems and
better economic and social conditions. Economic condition is an
important factor that signiﬁcantly affects health status. The ﬁnd-
ings of this study showed that patients with better economic
conditions had higher diabetes-speciﬁc self-efﬁcacy scores. This is
consistent with a study examining the factors affecting health
behaviors, which showed that participants with higher levels of
income had better self-care and self-efﬁcacy levels (Callaghan,
2006). Lee, Ahn and Kim (2009) also determined that patients
with higher incomes and/or education were more likely to visit
specialists, report better self-care practices (including higher self-
efﬁcacy) and control blood glucose better than those who
received generalist care.
Van der Ven, Weinger, Pouwer, Ader, & Van der Ploeg (2003)
determined that as the diabetes-speciﬁc self-efﬁcacy levels of
patients with type 1 diabetes increased, stress related to diabetes,
hypoglycemia fear, anxiety and depression decreased. However, in
this study, no signiﬁcant relationship was found between hypo-
glycemia fear and diabetes-speciﬁc self-efﬁcacy. This might be
because that study group consisted of patients with both type 1 and
type 2 diabetes. As patients with type 2 diabetes experience less
frequent hypoglycemia attacks, they report lower hypoglycemia
fear than patients with type 1 diabetes. In addition, they generally
begin to receive insulin therapy when they are older, and they
might not consider their health condition to be as serious as
patients with type 1 diabetes. Therefore, theymight not placemuch
importance on their diabetes care. Moreover, this study determined
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efﬁcacy levels than patients with type 2 diabetes. A qualitative
study evaluating the self-care decision processes of patients with
type 1 diabetes determined that patients with long diagnosis
periods also had increased experiences, which led them to make
more effective decisions and improve individualized strategies by
interpreting the signs from their bodies (Paterson & Sloan, 1994).
Patients’ active participation in diabetes care is one of the keys
to successful self-management. It is believed that improving
patients’ self-efﬁcacy will improve self-management (Sarkar,
Fisher, & Schillinger, 2006). Nurses have the great responsibility
of building up a patient’s conﬁdence to manage a healthy lifestyle
that leads to better diabetes control. For example, teaching patients
about balanced diets, daily exercise and evaluating their behaviors
and diabetes control can help them maintain newly acquired
behaviors. Patients must also evaluate the existing conditions and
gain the necessary skills to make proper decisions about their
diabetes self-management activities.
Conclusion
This study revealed that experiencing severe and recurrent
hypoglycemia attacks leads to hypoglycemia worry and hypogly-
cemia avoidance behaviors, which are directly related to hypogly-
cemic fear. Although this study found no relationship between
patients’ hypoglycemia fear and self-efﬁcacy levels, it is evident
that hypoglycemia worry and hypoglycemia avoidance behaviors
negatively affect diabetes control. Therefore, nurses should ask
about and evaluate patients’ hypoglycemia experiences (e.g.,
frequency, etiology, avoidance behaviors, treatment) at every
appointment. They should also ask patients to write these experi-
ences in a daily diary (including date, time, signs and symptoms,
treatment and potential causes). Hypoglycemia fear levels should
be evaluated, and patients with higher levels of hypoglycemia fear
should bemonitored closely. If necessary, they should be supported
by liaison psychiatrists. Patients’ hypoglycemia awareness should
be evaluated periodically, and programs aimed at improving
awareness should be created. Patients with a higher risk of severe
hypoglycemia and their families should be educated about the
prevention and treatment of hypoglycemia. Diabetes-speciﬁc self-
efﬁcacy scales provide knowledge about patients’ self-care capa-
bilities and self-conﬁdence; they are beneﬁcial during patient
assessments and while planning individualized care. Patients with
diabetes need lifelong education, support and empowermentdall
of which can be provided by nurses.
Limitations
Limitations of the current study include the fact that this was
a descriptive study, and causality could not be established. It was
carried out in a single diabetes centre. Although the Diabetes
Outpatient Clinic of the Istanbul Medical Faculty at Istanbul
University receives patients from various cities, the results cannot
be generalized to all diabetes patients. Moreover, data were ob-
tained by face-to-face conversations with the patients or by the
patients ﬁlling the forms out by themselves. Therefore, the reli-
ability of the data is limited by the self-reports of the patients.
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